[account_shop_links]
Pancreatic Cancer: Disease and Pipeline Analysis
$2,960.00 – $5,920.00
Licensing Options
- SINGLE-USER LICENSE
A Single-User License allows access to an individual user.
- ENTERPRISE-WIDE LICENSE
An Enterprise-Wide License allows access to all employees and sites within an organization.
Report Overview
In a market with few available therapies that exhibit limited effectiveness and a disease class which still classifies as “rare”, poor survival rates and lack of viable treatment options for Pancreatic cancer remain compelling reasons to develop new “Orphan” therapies to address largely unmet needs.
What you will learn:
- Information on over sixty potential new therapies in active development
- Incidence rate of pancreatic cancer for each of the major and emerging global markets
- Drug regulatory approval dynamics by country, including: Trial and recruitment environment, regulatory environment, competitive product landscape, and pricing and reimbursement environment
How you can use this report:
- Optimize your product’s global development and commercial strategies
- Identify drug candidates for partnering strategies
- Evaluate your pipeline against products currently in development
- Identify the most effective market entry strategies
Report Contents:
- Pancreatic Cancer Overview
- Commercial Rationale
- Environmental Analysis
- Clinical Development Pipeline
- Clinical Trial Environment
